首页 >
法规速递
-
Document: Annex - National provisions for SMEs applicable to the pharmaceutical sector-2025/5/15
2025-05-16查看详情 > -
六部门联合发布《关于将4-哌啶酮和1-叔丁氧羰基-4-哌啶酮列为易制毒化学品管理的公告》-2025/6/25
2025-06-26查看详情 > -
Document: Key elements form: Applicant’s proposal for a paediatric-investigation-plan opinion-2025/7/28
2025-07-29查看详情 > -
国家药监局关于莲芝消炎软胶囊和肾骨片转换为非处方药的公告（2025年第84号） -2025/9/12
2025-09-12查看详情 > -
Document: Minutes of the CVMP meeting 9-10 September 2025-2025/10/17
2025-10-17查看详情 > -
国家药监局综合司关于印发《药用辅料附录检查指导原则》《药包材附录检查指导原则》的通知-2025/11/21
2025-11-24查看详情 > -
Study of Sex Differences in the Clinical Evaluation of Medical Products-2025/12/15
2025-12-16查看详情 > -
Document: Questions and answers on Implementing Regulation (EU) 2025/1466: Amendment of Regulation (EU) No 520/2012 and Conclusion of the Signal Detection in EudraVigilance Pilot by marketing authorisation holders-2026/1/28
2026-01-29查看详情 > -
国家药监局关于发布仿制药参比制剂目录（第一百零二批）及调出参比制剂目录品种清单（第四批）的通告（2026年第7号）-2026/3/9
2026-03-10查看详情 > -
Document: CHMP PROM minutes for the meeting on 10 June 2025-2026/4/7
2026-04-08查看详情 >
